Seven Eight Capital’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-7,500
| Closed | -$394K | – | 621 |
|
|
2020
Q2 | $394K | Buy |
+7,500
| New | +$394K | 0.29% | 123 |
|
|
2020
Q1 | – | Sell |
-15,886
| Closed | -$720K | – | 633 |
|
|
2019
Q4 | $720K | Sell |
15,886
-16,589
| -51% | -$752K | 0.04% | 488 |
|
|
2019
Q3 | $1.24M | Buy |
32,475
+2,200
| +7% | +$83.7K | 0.07% | 393 |
|
|
2019
Q2 | $1.32M | Buy |
+30,275
| New | +$1.32M | 0.07% | 352 |
|
|
2018
Q4 | – | Sell |
-6,275
| Closed | -$308K | – | 670 |
|
|
2018
Q3 | $308K | Buy |
+6,275
| New | +$308K | 0.02% | 511 |
|
|
2017
Q3 | – | Sell |
-957
| Closed | -$46K | – | 566 |
|
|
2017
Q2 | $46K | Buy |
+957
| New | +$46K | 0.01% | 486 |
|
|
2017
Q1 | – | Sell |
-2,401
| Closed | -$78K | – | 640 |
|
|
2016
Q4 | $78K | Sell |
2,401
-5,500
| -70% | -$179K | 0.02% | 476 |
|
|
2016
Q3 | $270K | Buy |
7,901
+6,000
| +316% | +$205K | 0.08% | 286 |
|
|
2016
Q2 | $64K | Buy |
+1,901
| New | +$64K | 0.02% | 435 |
|
|
2016
Q1 | – | Sell |
-801
| Closed | -$62K | – | 650 |
|
|
2015
Q4 | $62K | Buy |
801
+800
| +80,000% | +$61.9K | 0.04% | 415 |
|
|
2015
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 649 |
|
|
2015
Q2 | – | Sell |
-601
| Closed | -$53K | – | 635 |
|
|
2015
Q1 | $53K | Buy |
+601
| New | +$53K | 0.09% | 280 |
|
|
2014
Q4 | – | Sell |
-3,501
| Closed | -$339K | – | 609 |
|
|
2014
Q3 | $339K | Buy |
+3,501
| New | +$339K | 0.26% | 136 |
|
|
2014
Q2 | – | Sell |
-10,100
| Closed | -$707K | – | 579 |
|
|
2014
Q1 | $707K | Buy |
+10,100
| New | +$707K | 0.61% | 40 |
|